Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus

Abstract Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.

Guardado en:

Detalles Bibliográficos
Autores principales:	Panagiotis Pavlou, Vaios Koutroukas, Catherine Lissett, Jamie C. Smith
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	colesevelam diabetes hypoglycemia type 1 diabetes Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/99ee04b4939d493592638149b96eed73
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:99ee04b4939d493592638149b96eed73
record_format	dspace
spelling	oai:doaj.org-article:99ee04b4939d493592638149b96eed732021-12-02T07:55:57ZColesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus2050-090410.1002/ccr3.4830https://doaj.org/article/99ee04b4939d493592638149b96eed732021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4830https://doaj.org/toc/2050-0904Abstract Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.Panagiotis PavlouVaios KoutroukasCatherine LissettJamie C. SmithWileyarticlecolesevelamdiabeteshypoglycemiatype 1 diabetesMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	colesevelam diabetes hypoglycemia type 1 diabetes Medicine R Medicine (General) R5-920
spellingShingle	colesevelam diabetes hypoglycemia type 1 diabetes Medicine R Medicine (General) R5-920 Panagiotis Pavlou Vaios Koutroukas Catherine Lissett Jamie C. Smith Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
description	Abstract Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.
format	article
author	Panagiotis Pavlou Vaios Koutroukas Catherine Lissett Jamie C. Smith
author_facet	Panagiotis Pavlou Vaios Koutroukas Catherine Lissett Jamie C. Smith
author_sort	Panagiotis Pavlou
title	Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_short	Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_full	Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_fullStr	Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_full_unstemmed	Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_sort	colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/99ee04b4939d493592638149b96eed73
work_keys_str_mv	AT panagiotispavlou colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus AT vaioskoutroukas colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus AT catherinelissett colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus AT jamiecsmith colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus
_version_	1718399115130306560

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus

Ejemplares similares